Breaking News on Early Stage Alzheimer's Treatment
President & CEO Update
Alzheimer's Association
This message is sent to all Alzheimer's Association and Alzheimer's
Impact Movement board members, all Alzheimer's Association staff, and
volunteers and supporters of AIM and the Alzheimer's Association.
Today, we are living history: the U.S. Food and Drug Administration
(FDA) granted traditional approval of lecanemab, sold under the brand
name Leqembi, for the treatment of early-stage Alzheimer's
disease. This is the first traditional approval granted for an
Alzheimer's treatment that changes the underlying course of the
disease. Learn more here.
[link removed]
In addition, the Centers for Medicare & Medicaid Services (CMS)
announced it will cover the treatment through Medicare. Read our
statement here.
[link removed]
The Alzheimer's Association has long been the leading voice on
behalf of people living with this fatal disease. They deserve the
opportunity to discuss and choose, with their doctors and family,
whether an approved treatment is right for them with as few barriers
as possible.
We owe a debt of thanks to all who worked to make this happen:
bipartisan members of Congress, state attorneys general, clinicians,
and, most importantly, the thousands of our volunteers from
communities all across the country.
[link removed]
[link removed]
[link removed]
While this is a tremendous step forward, the Alzheimer's
Association's work is far from done. We won't rest until
everyone living with Alzheimer's - at any stage -
can get the treatment, care and support they need and deserve.
The next few weeks and months are critically important. We will work
closely with CMS, other payers, the physician community, our health
systems and other community partners to work toward a smooth rollout
for patients who can benefit.
Thank you for all you do to move our mission forward. You can always
find additional information at alz.org or at our 24/7 Helpline (
[link removed]
800.272.3900).
Joanne Pike, DrPH
President & CEO
CONNECT WITH US
Facebook
Twitter
Pinterest
Blog
[link removed]
[link removed]
[link removed]
[link removed]
Alzheimer's Association
Alzheimer's Association
225 N. Michigan Ave., FL 17, Chicago, IL
60601
800.272.3900 | alz.org
tel:800.272.3900
[link removed]
©2023 Alzheimer's Association. All
rights reserved. Alzheimer's Association is a not-for-profit 501(c)(3)
organization.
Contact Us
|
Privacy Policy
|
Unsubscribe
[link removed]
[link removed]
[link removed]
To unsubscribe from all future email, paste the following URL into your browser:
[link removed]
